In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of $248.61. According to InvestingPro data, the medical technology giant, with a ...

The chart below shows the one year performance of BDX shares, versus its 200 day moving average: BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market ...

The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...

For the quarter ended December 2024, Becton Dickinson (BDX) reported revenue of $5.17 billion, up 9.8% over the same period last year. EPS came in at $3.43, compared to $2.68 in the year-ago quarter.

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC ...

Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

BDX's acquisition of Edwards Lifesciences ... Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any ...

Let’s check out the factors that have shaped BDX’s performance prior to this announcement. On the fourth quarter fiscal 2024earnings callin November 2024, management shared a few updates about ...